When thalidomide came to market in the 1950s as a morning sickness treatment, no one imagined the many cases of birth defects that would result from use of the drug. More than 50 years later, a small Madison-based stem cell company is selling a research product that could have prevented what some have called one of the biggest medical tragedies of modern times. Read full Journal Sentinel story here.
- ‘Succeed’ panels focus on resources June 4-5 at Wisconsin Entrepreneurs’ ConferenceMay 24, 2019
- ‘Diligent (Baker’s) Dozen’ will present live June 4 at Wisconsin Entrepreneurs’ ConferenceMay 24, 2019
- Finalists to share wide range of prizes, cash in 2019 Governor’s Business Plan ContestMay 23, 2019
- Tech Council board member Chand wins major manufacturing awardMay 23, 2019
- InsideWis: Midwest emerging as venture hot spot: Will Wisconsin step up?May 23, 2019